Summary -

Key Takeaways Explained for a Non-Medical Audience

– Patients with normal glucose tolerance can still have significant impairments in insulin sensitivity.

– Fasting and post-load insulin levels were significantly higher in CHD patients with NGT compared to controls.

– Elevated insulin levels were positively correlated with the severity of coronary artery stenosis.

– Traditional oral glucose tolerance tests may not fully capture underlying insulin resistance in patients.

– Fasting glucose alone is not a reliable marker for assessing cardiovascular risk in NGT individuals.
– Hyperinsulinemia, even in the presence of normal glucose, is independently associated with coronary artery disease

– The study supports the hypothesis that insulin resistance precedes overt hyperglycemia and contributes to atherosclerosis.

– Higher insulin and C-peptide levels suggest a compensatory mechanism due to peripheral insulin resistance.

– The results underscore the need for more sensitive markers of metabolic health beyond glucose levels.

– Individuals classified as “metabolically healthy” by glucose tolerance may still be at high risk for CHD.

– Insulin resistance contributes to endothelial dysfunction, a key mechanism in atherogenesis.

– Elevated insulin may promote vascular smooth muscle proliferation and atherosclerotic plaque development.

– The study adds to the growing evidence that metabolic dysfunction can be present long before diabetes is diagnosed.

– Subclinical metabolic stress, driven by poor insulin signaling, may be an early and under-recognized driver of heart disease.

– Assessment of insulin and C-peptide levels could improve early detection of cardiovascular risk.